Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals Limited has disclosed a scheduled investor conference meeting hosted by Ambit Capital on May 25, 2026 at 11:00 AM IST in Mumbai. The meeting will be conducted in physical mode and includes both group and one-on-one sessions with company officials. This is a routine regulatory filing under SEBI Listing Regulations, specifically Regulation 30(6) read with Schedule III. The company has clarified that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) will be shared during the interactions.
This is a standard investor relations activity disclosure with no direct impact on the stock. It demonstrates the company's engagement with institutional investors and compliance with SEBI disclosure norms, which is routine and expected from listed companies.